1[1]Saag MS, Powderly WG, Cloud GA, et al.Comparison of amphotericin B with fluconazole in the treatment of acute AIDS associated cryptococcal meningitis.N Engl J Med, 1992, 326 (2):83-89.
2[2]van der Horst C, Saag MS, Cloud GA, et al.Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome.N Engl J Med, 1997, 337 (1):15-21.
3[3]Powderly WG.Current approach to the acute management of cryptococcal infections.J Infect, 2000, 41 (1):18-22.
4[4]Mayanja Kizza H, Oishi K, Mitarai S, et al.Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS.Clin Infect Dis, 1998, 26 (6):1362-1368.
5[5]Yamazumi T, Pfaller MA, Messer SA, et al.In vitro activities of ravuconazole (BMS 07147) against 541 clinical isolates of cryptococcus neoformans.Antimicro Agents Chemother, 2000, 44 (2):383-386.
6[6]Saag MS, Cloud GC, Graybill JR, et al.A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS associated cryptococcal meningitis.Clin Infect Dis, 1999, 28 (2):291-296.
7[7]CAESAR Coordinating Committee.Randomised trial of addition of lamivu dine or lamivudine plus loviride to zidovudine containing regimens for patients with HIV 1 infection:the CAESAR trial.Lancet, 1997, 349 (9063):1413-1421.
8[8]Palella FJ, Delaney K, Moorman A, et al.Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.N Engl J Med, 1998, 338 (13):853-860.
9[9]Sacktor N, Lyles RH, Skolasky R, et al.HIV associated neurologic disease incidence changes:multicenter AIDS cohort studay, 1990 1998.Neurology, 2001, 56 (1):57-60.
10[10]Graybill JR, Sobel J, Saag M, et al.Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis.Clin Infect Dis, 2000, 30 (1):47-54.
